For some people, a rare genetic mutation makes dementia inescapable. Three sisters have decided to confront fate with a genetic test and have joined a research project on possible treatments.
THE U S FDA ACCEPTS AND GRANTS PRIORITY REVIEW FOR EISAI S BIOLOGICS LICENSE APPLICATION OF LECANEMAB FOR EARLY ALZHEIMER S DISEASE UNDER THE ACCELERATED APPROVAL PATHWAY streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Digital Tools Abound, Yet Remote Biomarkers for FTD Remain Exploratory alzforum.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from alzforum.org Daily Mail and Mail on Sunday newspapers.
TOKYO and CAMBRIDGE, Mass., May 10, 2022 - (JCN Newswire) - Eisai Co., Ltd. and Biogen Inc. announced today that Eisai has completed the rolling submission to the U.S. Food and Drug Administration (FDA)